{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:58Z","timestamp":1786119298188,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/aog.0b013e3181998877","type":"journal-article","created":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T03:28:40Z","timestamp":1247714920000},"page":"437-440","source":"Crossref","is-referenced-by-count":6,"title":["Insights Into Angiogenic Imbalances During Pregnancy"],"prefix":"10.1097","volume":"114","author":[{"given":"Jimmy","family":"Espinoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Uckele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Bronsteen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley M.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210126","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia [published erratum appears in N Engl J Med 2006;355:1840].","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"R2-10-20210126","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1056\/NEJMc052721","article-title":"Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops.","volume":"354","author":"Stepan","year":"2006","journal-title":"N Engl J Med"},{"key":"R3-10-20210126","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/14767050600922677","article-title":"A role of the anti-angiogenic factor sVEGFR-1 in the \u2018mirror syndrome\u2019 (Ballantyne\u2019s syndrome).","volume":"19","author":"Espinoza","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R4-10-20210126","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/humrep\/dem042","article-title":"Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome.","volume":"22","author":"Kosaka","year":"2007","journal-title":"Hum Reprod"},{"key":"R5-10-20210126","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00313020601137367","article-title":"The pathology of gestational trophoblastic disease: recent advances.","volume":"39","author":"Wells","year":"2007","journal-title":"Pathology"},{"key":"R6-10-20210126","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia.","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"R7-10-20210126","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/humrep\/del005","article-title":"Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.","volume":"21","author":"Pau","year":"2006","journal-title":"Hum Reprod"},{"key":"R8-10-20210126","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0002-9343(99)00261-2","article-title":"Cholesterol lowering and endothelial function.","volume":"107","author":"Vogel","year":"1999","journal-title":"Am J Med"},{"key":"R9-10-20210126","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1172\/JCI18015","article-title":"Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?","volume":"111","author":"Luttun","year":"2003","journal-title":"J Clin Invest"},{"key":"R10-10-20210126","article-title":"Pathology of the human placenta.","author":"Benirschke","year":"2006"},{"key":"R11-10-20210126","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","article-title":"Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia.","volume":"50","author":"Li","year":"2007","journal-title":"Hypertension"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200908001-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:16Z","timestamp":1786038916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200908001-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181998877","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}